Add The Wire As Your Trusted Source
For the best experience, open
https://m.thewire.in
on your mobile browser.
AdvertisementAdvertisement

Johnson & Johnson to Work With Indian Govt to Compensate Recalled Hip Implants

After a government panel last month recommended that the company pay compensation to patients who suffered from artificial hip implants, Johnson and Johnson has said it would work with the Indian government.
After a government panel last month recommended that the company pay compensation to patients who suffered from artificial hip implants, Johnson and Johnson has said it would work with the Indian government.
johnson   johnson to work with indian govt to compensate recalled hip implants
The panel had also suggested that the company pay compensation of around Rs 20 lakh to the affected patients.. Credit: Reuters/File Photo
Advertisement

Mumbai: Johnson & Johnson (J&J) said on Friday it would work with the Indian government to compensate patients who suffered from artificial hip implants the US healthcare company recalled eight years ago.

Last month, a government panel recommended that J&J pay compensation of at least 2 million rupees ($27,812) to each patient who received an ASR hip implant in India, an estimated 4,700 people. The federal government has asked states to help the patients get relief soon.

“We have always been and continue to be fully committed to supporting all ASR patients in India, and the rest of the world,” a J&J spokeswoman said in a statement emailed to Reuters.

“In light of the recent committee report, we are seeking to work with the Indian government to develop an appropriate process for providing further support and compensation for patients in need,” she added.

The ASR hip implants were recalled in 2010 after data suggested they failed at a higher-than-expected rate.

Advertisement

In 2013, the firm agreed to pay nearly $2.5 billion to settle thousands of lawsuits from patients in the US who said they were injured by the implants.

In India, the company paid $2 million to patients for repeat surgeries and about $250,000 in related diagnostic costs under its ASR reimbursement programme, but the government panel criticised J&J for offering no compensation.

Advertisement

About 93,000 people worldwide received ASR implants, the panel said in its report to the government, about 4,700 of them in India.

Metal hip implant systems such as ASR were designed to be more durable than a traditional metal-on-plastic, ball-and-socket design. But many Indian patients suffered adverse reactions to the implant, the panel said.

Advertisement

J&J entered the Indian market in 1947 when it started selling its now-ubiquitous baby powder. The company has in recent years faced issues such as price caps on medical devices.

Advertisement

(Reuters)

This article went live on September seventh, two thousand eighteen, at fifteen minutes past four in the afternoon.

The Wire is now on WhatsApp. Follow our channel for sharp analysis and opinions on the latest developments.

Advertisement
Advertisement
tlbr_img1 Series tlbr_img2 Columns tlbr_img3 Multimedia